<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412019000900594</article-id>
<article-id pub-id-type="doi">10.24245/gom.v87i9.3452</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Punto de corte de la concentración basal de FSH como factor pronóstico para la obtención de ovocitos en ciclos de FIV con protocolo antagonista]]></article-title>
<article-title xml:lang="en"><![CDATA[Cut-off value in FSH levels as a prognostic factor for oocyte yield in IVF cycles with antagonist protocol]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guarneros-Valdovinos]]></surname>
<given-names><![CDATA[Luis Rodrigo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Benítez-Castro]]></surname>
<given-names><![CDATA[Kenia Lizbeth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carballo-Mondragón]]></surname>
<given-names><![CDATA[Esperanza]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Kably-Ambe]]></surname>
<given-names><![CDATA[Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Ángeles Lomas Centro Mexicano de Fertilidad ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Ángeles Lomas Centro Mexicano de Fertilidad ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Ángeles Lomas Centro Mexicano de Fertilidad ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital Ángeles Lomas Centro Mexicano de Fertilidad ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<volume>87</volume>
<numero>9</numero>
<fpage>594</fpage>
<lpage>599</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412019000900594&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412019000900594&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412019000900594&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  OBJETIVO: Determinar el punto de corte de la concentración basal de FSH y su valor pronóstico en la obtención de ovocitos con protocolo de antagonistas en ciclos de fertilización in vitro.  MATERIALES Y MÉTODOS: Estudio retrospectivo, efectuado en pacientes en el primer ciclo de fertilización in vitro con un protocolo antagonista. Se formaron dos grupos de acuerdo con las concentraciones basales de FSH: en el grupo 1 permanecieron las pacientes con concentración de FSH menor de 7 mIU/mL y en el grupo 2 con concentraciones mayores de 7 mIU/mL. Parámetros de estudio: dosis total de gonadotropinas, pico de estradiol, cantidad de ovocitos recuperados, de ovocitos en metafase II, de embriones disponibles para transferencia y tasa de embarazo. Para comparar las diferencias de medias entre ambos grupos se realizó la prueba de t de Student. El análisis estadístico se realizó con el programa JMP 9.0. El valor de p &lt; 0.05 se consideró estadísticamente significativo.  RESULTADOS: Se registraron 1441 pacientes: 927 en el grupo 1 y 514 en el grupo 2. Las mujeres del grupo 1 reportaron menor edad (34.3 vs 35.3; p &lt; 0.05), mayor cantidad de ovocitos (11.15 vs 8.26; p &lt; 0.05) y, en general, ovocitos maduros (7.4 vs 5.3; p &lt; 0.05). No se encontró diferencia significativa en las tasas de embarazo entre ambos grupos (27.98 vs 28.92; p = 0.54).  CONCLUSIONES: La concentración basal de FSH mayor de 7 mIU/mL se correlaciona significativamente con menor cantidad de ovocitos recuperados en los ciclos de fertilización in vitro con protocolo de antagonistas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  BACKGROUND: Measurement of follicle-stimulating hormone (FSH) is used as a marker of ovarian reserve. The number of oocytes obtained is significantly lower among women with higher FSH levels.  OBJECTIVE:  To know the cut-off level of FSH and its prognostic value in the number of oocytes retrieved.  METHODS: Retrospective study performed on patients in their first cycle of in vitro fertilization with an antagonist protocol. The patients were separated into two groups according to the basal FSH concentrations: group 1 FSH lower than 7 mIU / mL, group 2 with concentrations greater than 7 mIU / mL. Compared variables among groups were: age, total dose of gonadotropins, peak of estradiol, total number of oocytes retrieved, number of oocytes in metaphase II, number of embryos available for transfer, and the pregnancy rate.  RESULTS:  Group 1 included 927 women, while group 2 included 514 women. Age was lower in group 1 (34.3 vs. 35.3, p &lt;0.05). In group 1 more oocytes were obtained (11.15 vs 8.26, p&lt;0.05), as well as more mature oocytes (7.4 vs 5.3, p &lt;0.05). There was no significant difference in pregnancy rates between both groups (27.98 vs. 28.92, p = 0.54).  CONCLUSIONS:  A baseline FSH&gt; 7 correlates significantly with obtaining fewer oocytes in IVF treatment cycles with antagonist protocols.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[FSH]]></kwd>
<kwd lng="es"><![CDATA[FIV]]></kwd>
<kwd lng="es"><![CDATA[respuesta ovárica]]></kwd>
<kwd lng="es"><![CDATA[ovocitos obtenidos]]></kwd>
<kwd lng="en"><![CDATA[FSH]]></kwd>
<kwd lng="en"><![CDATA[IVF]]></kwd>
<kwd lng="en"><![CDATA[Ovarian response]]></kwd>
<kwd lng="en"><![CDATA[Recover oocyte]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Loendersloot]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Hum Reprod Update]]></source>
<year>2010</year>
<volume>16</volume>
<page-range>577-89</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferraretti]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ESHRE consensus on the definition of &#8220;poor response&#8221; to ovarian stimulation for in vitro fertilization: the Bologna criteria]]></article-title>
<source><![CDATA[Hum Reprod]]></source>
<year>2011</year>
<volume>26</volume>
<page-range>1616-24</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>American Society for Reproductive Medicine</collab>
<article-title xml:lang=""><![CDATA[Testing and interpreting measures of ovarian reserve: a committee opinion]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2015</year>
<page-range>103:e9-17</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weghofer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction]]></article-title>
<source><![CDATA[Hum Reprod]]></source>
<year>2005</year>
<volume>20</volume>
<page-range>2448-2</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barad]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2007</year>
<volume>109</volume>
<page-range>1404-10</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Rooij]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2003</year>
<volume>79</volume>
<page-range>482-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function]]></article-title>
<source><![CDATA[Reprod Biol Endocrinol]]></source>
<year>2015</year>
<volume>13</volume>
<numero>63</numero>
<issue>63</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Rooij]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-follicle stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2004</year>
<volume>81</volume>
<page-range>1478-85</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Spandorfer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fasouliotis]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2005</year>
<volume>83</volume>
<page-range>37-41</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sabatini]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relevance of basal serum FSH to IVF outcome varies with patient age]]></article-title>
<source><![CDATA[Reprod Biomed Online]]></source>
<year>2008</year>
<volume>17</volume>
<page-range>10-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Esposito]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A moderately elevated day 3 SFH concentration has limited predictive value, especially in younger women]]></article-title>
<source><![CDATA[Hum Reprod]]></source>
<year>2002</year>
<volume>17</volume>
<page-range>118-23</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jurema]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Bracero]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[JE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2003</year>
<volume>80</volume>
<page-range>1156-61</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chuang]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2003</year>
<volume>79</volume>
<page-range>63-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abdalla]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An elevated basal FSH reflects a quantitative rather than a qualitative decline of ovarian reserve]]></article-title>
<source><![CDATA[Hum Reprod]]></source>
<year>2004</year>
<volume>19</volume>
<page-range>893-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toner]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2013</year>
<volume>99</volume>
<page-range>1825-30</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
